Abstract
Flora Tang started biotech consulting on drug discovery operation and technology in 2007. Flora has extensive pharmaceutical experiences working at Amgen as Director of Research; SUGEN (subsidiary of Pharmacia) as Director of Discovery Technology; Eli Lilly; and GlaxoSmithKline. The scope of her work experiences involves high throughput biology using cutting-edge technologies and managing business operations. Flora started applying high content screening to drug discovery process soon after the inception of HCS.
Combinatorial Chemistry & High Throughput Screening
Title: Meet the Guest Editors
Volume: 12 Issue: 9
Author(s): Flora Tang and Jinghai Jim Xu
Affiliation:
Abstract: Flora Tang started biotech consulting on drug discovery operation and technology in 2007. Flora has extensive pharmaceutical experiences working at Amgen as Director of Research; SUGEN (subsidiary of Pharmacia) as Director of Discovery Technology; Eli Lilly; and GlaxoSmithKline. The scope of her work experiences involves high throughput biology using cutting-edge technologies and managing business operations. Flora started applying high content screening to drug discovery process soon after the inception of HCS.
Export Options
About this article
Cite this article as:
Tang Flora and Xu Jim Jinghai, Meet the Guest Editors, Combinatorial Chemistry & High Throughput Screening 2009; 12 (9) . https://dx.doi.org/10.2174/138620709789383295
DOI https://dx.doi.org/10.2174/138620709789383295 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers